000			01959 a2200577 4500
005			20250513130030.0
264		0	_c19971113
008			199711s 0 0 eng d
022			_a0009-9236
024	7		_a10.1016/S0009-9236(97)90031-X _2doi
040			_aNLM _beng _cNLM
100	1		_aOdani, A
245	0	0	_aGenetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy. _h[electronic resource]
260			_bClinical pharmacology and therapeutics _cSep 1997
300			_a287-92 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAnticonvulsants _xpharmacokinetics
650	0	4	_aAryl Hydrocarbon Hydroxylases
650	0	4	_aBayes Theorem
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aCytochrome P-450 CYP2C19
650	0	4	_aCytochrome P-450 CYP2C9
650	0	4	_aCytochrome P-450 Enzyme System _xchemistry
650	0	4	_aEpilepsy _xdrug therapy
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Enzymologic _xgenetics
650	0	4	_aGenotype
650	0	4	_aHeterozygote
650	0	4	_aHumans
650	0	4	_aInfant
650	0	4	_aJapan
650	0	4	_aMale
650	0	4	_aMixed Function Oxygenases _xchemistry
650	0	4	_aMutation _xgenetics
650	0	4	_aPhenytoin _xblood
650	0	4	_aPolymerase Chain Reaction
650	0	4	_aPolymorphism, Genetic
650	0	4	_aSteroid 16-alpha-Hydroxylase
650	0	4	_aSteroid Hydroxylases _xchemistry
700	1		_aHashimoto, Y
700	1		_aOtsuki, Y
700	1		_aUwai, Y
700	1		_aHattori, H
700	1		_aFurusho, K
700	1		_aInui, K
773	0		_tClinical pharmacology and therapeutics _gvol. 62 _gno. 3 _gp. 287-92
856	4	0	_uhttps://doi.org/10.1016/S0009-9236(97)90031-X _zAvailable from publisher's website
999			_c9305549 _d9305549